CD8A and COVID-19: The involvement of CD4+ and CD8+ T cells in the immune response reduces the severity of disease (1–3), and the presence of pre-existing SARS-CoV-2-specific T cells can prevent the development of COVID-19 (4, 5) and decrease the risk of reinfection (6).